Diabetes Information [Return To Home Page]

Benfotiamine And Diabetic Retinopathy


Damage from diabetes can occur in different areas of the eye. It can occur to the cornea, nerves controlling the muscles of the eye, the lens, optic nerve and retina. The retina is the complication that most people and medical professionals think of first in terms of diabetic complications.

Diabetic retinopathy is simply damage to the light sensitive retina. This damage is brought about by hyperglycemia, the medical term for high blood sugar. Retinopathy is directly responsible for approximately 12,000 to 24,000 cases of legal blindness every year in the USA alone. It is reported that there are over 200,000 cases each year globally.

Diabetic complications are even more insidious than these numbers because there are several other types of diabetic eye disease created wholly or in part by high blood sugar in diabetics.

What Can Be Done To Prevent Eye Disease?

It stands to reason that the more informed a person is about a particular situation the better equipped they will be to handle it. Diabetic eye disease is just such a case in point. We need to think of the whole person and not just the eyes when discussing diabetic education because diabetic complications run from eye disease, heart disease, nerve damage, kidney damage, etc. Although benfotiamine has been found useful for all of the above, for the sake of this article in terms of prevention, we will discuss diabetic eye disease in terms of diabetic retinopathy.

Diabetic retinopathy is a disease that every diabetic faces the possibility of suffering from somewhere in the course of their disease. The better patients of diabetes are equipped to handle their disease, the lower their risk that they will develop retinopathy. If retinopathy does develop in a patient who is doing all he/she can do to lessen the impact of blood sugar on their bodies, the better chance that they can live productive lives despite the complications and the slower such complications will progress.

What Works Best?

Unfortunately, there are very few options that are showing much promise for the diabetic in terms of diabetic complications. Benfotiamine has been suggested recently to be a strong deterrent against the development of diabetic retinopathy and also shown to slow its progression significantly if it develops. It is showing great promise in the arena of retinopathy, neuropathy and heart/circulatory conditions brought about by excess sugar in the cells.

Benfotiamine, a lipid soluble derivative of water soluble vitamin B1 (thiamine), has been used for the past 12 years in Europe for the treatment of neuropathy, retinopathy as well as heart and circulatory conditions and has shown no adverse effects.

Much of the current research on benfotiamine can be discovered by typing the term benfotiamine into a search engine such as google, AOL, yahoo, etc.

Conclusion

Diabetic complications are a reality that must be an accepted possibility for every diabetic. Diabetic education is highly necessary so that the diabetic community is able to make informed decisions as to their treatment and prevention methodologies. There are few things that show great promise in preventing and/or helping neuropathy, retinopathy, heart and circulatory problems brought about by diabetes. Keeping blood sugar levels close to normal along with adequate exercise in line with the abilities of each individual has shown to help slow the onset of diabetic complications.

Benfotiamine is a nutritional supplement that has shown to be helpful in Europe over the past 12 years in terms of diabetic complications and is now available in the United States, and might be worth the time to investigate further. How about for the diabetic who faces the insidious nature of diabetic complications?

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy. He can be reached at:

Phone: 505.354.0526

web site: http://www.emuhealthproducts.com/benfotiamine.html


MORE RESOURCES:

The Guardian

Diabetes quadruples birth defects risk, say researchers
BBC News
By James Gallagher Health and science reporter, BBC News The risk of birth defects increases four-fold if the pregnant mother has diabetes, researchers say. The Newcastle University study, published in the journal Diabetologia, analysed data from more ...
Diabetes in pregnancy ups birth defects riskTimes of India
Diabetes 'raises birth defect risk'The Press Association
Women with diabetes warned to take precautions when having a babyThe Guardian
Daily Mail
all 211 news articles »


US Drug Watchdog Expands Their Initiative for Diabetics Who Used the Diabetes ...
San Francisco Chronicle (press release)
The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer. We now believe the number of diabetics, who used the diabetes drug called Actos, ...

and more »


TopNews United States

Diabetes: Celebrating The Silent Killer
Leadership Newspapers
With the worsening incidence of diabetes sweepiing across the world, EZRA IJIOMA examines the different types of diabetes and reasons for its high incidence in Nigeria. In 2003, when he was 21 years old, Ken developed a puzzling, unquenchable thirst.
A Stomach Bug and DiabetesdailyRx
Diabetes is his daily challengeBlacktown Sun
Former office manager, a diabetic, sues Casper company for discriminationCasper Star-Tribune Online
MLB.com -The Cypress Times -TopNews United States
all 11 news articles »


Take steps to detect, reverse pre-diabetes
Wisconsin Rapids Tribune
Pre-diabetes is a condition in which a person's blood sugar is elevated but not high enough to be classified as type 2 diabetes. It's a very important condition to understand because there are so many people who, if they realized they had pre-diabetes, ...
The Diabetic Week in Review -- Week Ending 4 February 2012Examiner.com

all 2 news articles »


Research and Markets: Brazil Diabetes Care Devices Market Outlook to 2017 ...
SunHerald.com
GlobalData's new report, Brazil Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Brazil Diabetes Care Devices market. The report provides value (USD million), volume (units) and ...

and more »


Diabetes amputations drop, but disease expands
SouthCoastToday.com
By ANIKA CLARK The Centers for Disease Control and Prevention published good news recently for the nation's diabetic adults. In 2008, substantially fewer of them 40 and older received lower limb amputations than they had 12 years prior.



GPB

Diabetes Study Focuses On City Workers
GPB
By Joshua Stewart A new study at UGA will focus on preventing diabetes among government works in Athens-Clarke County, Columbus and Macon by helping them manage their weight. Obesity is a key cause of Type II diabetes. (Photo Courtesy of Jeff Mather ...



PR Web (press release)

Diabetes is One of the Fastest Deadly Growing Diseases around the World
PR Web (press release)
According to the Centers for Disease Control in the USA: Diabetes is an epidemic. 17 million Americans have diabetes with 5.9 million completely unaware that they even have the disease. Diabetes is the 5th leading cause of death in the United States ...



Medical experts meet in S'pore for diabetes workshop
Channel News Asia
SINGAPORE: Leading international experts in type 2 diabetes are in Singapore to address specific challenges and opportunities of bariatric or metabolic surgery for Asian patients and health care systems. The Asia-Pacific Workshop on Metabolic Surgery ...

and more »


The Curse of Amylin's Diabetes Drug Approval
TheStreet.com
... after more than two and a half years, two FDA rejection letters, and at least a dozen amendments to the application, Amylin Pharmaceuticals(AMLN) received FDA approval for Bydureon, a once-weekly formulation of its existing diabetes drug Byetta.


Google News






home | site map
© 2006